zilongwang/ReadingBank huggingface dataset:
Section 3) Details of the parent or carer of the person you are concerned about (if relevant) Name(s) Contact details (including address) Have they been informed of the concern? (please delete) The parent/carer should not be informed if doing so would put the child/adult at risk of harm Yes No If they have not been informed of the concern, please give your reason why: Section 4) Actions taken Who has been informed about the concern? (e.g. Children’s Services, Police, LTA, etc.) Name Organisation and role Contact details Date informed What did they say/do? What else has been done about the concern (if anything)?
Long Term Athlete Development (LTAD) Recommendations for Local Associations Ringette Saskatchewan’s Ultimate Goals – desired end state Vision (Why?) Retain athletes – keeping children in the sport for life Make ringette enjoyable for all no matter the skill To prepare for a competition restructure from Ringette Canada – a new restructure that hasn’t been released yet. Strategy (How?) Doing the right things at the right time based on LTAD four pillars technical, physical, psychological, and Life Skills of a child To have an athlete-centered approach- placing the needs of the athlete before the interest of anything else Increase meaningful competition (end to end) at all levels. Results (Measures) Increase skilled athletes- improving a skill enhances the ability to participate, and increased participation makes things fun Increase competitiveness in our excellence stream- if athletes are being taught the right skill at the right time, improvement should be seen at all levels. Better results at Westerns, and Nationals Ringette Saskatchewan Medium Term Goals- actions that need to take place Coaches and volunteers are knowledgeable about LTAD The right actions are taking place in regards to athletes Athlete-centered coaching- developing decision makers The right skill is being taught at the right time Improved skill U14 and below Always with an eye on “development-stage” appropriateness (LTAD) Focus beyond wins & losses/goals & assists ie. skills outcomes: both team and individual
Table Topic: Healthcare Access There are lots of access-related challenges: Lack of access to information/awareness Transportation Changing addresses The system is confusing & dysfunctional Language Work schedules Providers not accepting Medicaid Lack of culture of prevention Funding needs to be large/long-term and need sustainable solutions Solutions: Meet people where they are: “Rural areas: lack of access; telemedicine does work; also meet people where they are, e.g. combine reproductive health with primary care.” Tele-medicine is promising “Telehealth works—cardiac and diabetes.” Face-to-face help with computer applications and telehealth interfaces There’s a need for professional development and education: “Education of primary care providers and schools.” “Professional development for teachers, doctors, especially cultural competency.” Public/Private Solutions “Maine’s unique culture: shared needs assessment is exciting (state and health systems). Can we build off that? Reach out to CAPS, UW’s?” “Creative approaches in other rural areas?” Table Topic: Healthy Aging Trends: Liveable communities: “Healthy-living - elders moving into downtown areas where more services are available nearby.” Aging in place “Educating that services are available at home.” “How does aging in place affect supply and demand? Resources are over-saturated.” “Need a solution for the middle sector between assisted and totally independent.” Issues around family support “Family support is not as prevalent.” “Caregiver stress” Particular challenges for elders: Transportation Isolation Lack of information Lack of access Housing availability Dementia People in independent living facilities more impaired Care for low-income elders Solutions: Volunteering “More inducements to volunteer (tax credits, etc)” “Tap into immigrant retired population.”
PERFORMANCE EVALUATON STANDARD (PES) TORP Number: #XXXX Position Title: Enter the admin level Complete the table below so that it is applicable and tied to the duties/tasks/deliverables outlined in the statement of work. See below for an example. Deliverable Performance Standard Acceptable Quality Level Method Used/Frequency Compliance Level and Date 1. Work products and documents related to … Example: Needed on a daily basis 95% Annual review 2. [add other deliverables as needed for your task order] Example: Prepared by the established deadlines. 95% Annual review 3. [add other deliverables as needed for your task order] Example: Performed on an ongoing basis 95% Annual review 4. [add other deliverables as needed for your task order] Example: Completed by the established deadlines 95% Annual review
Enter Text Here 4. Summarize the price/cost proposed by the selected Awardee. Enter the value for the administrative cost and management cost for each contract period and press the arrow keys or tab key to move to the next field. Contract Period Administrative Cost Management Cost Total Cost Base Year $0.00 $0.00 $0.00 Option Year 1 $0.00 $0.00 $0.00 Option Year 2 $0.00 $0.00 $0.00 Option Year 3 $0.00 $0.00 $0.00 Option Year 4 $0.00 $0.00 $0.00 TOTAL $ 0.00 $ 0.00 $0.00
LSCB Quality Assurance: Monitoring this strategy. Strategic objective Action QA Reporting to To improve outcomes for children where there are concerns about neglect LSCB members to promote the practice standards in this strategy, through communications and training. Carry out case audits to measure compliance with neglect standards. LSCB executive group Ensure understanding of prevalence and impact on capacity. The LSCB will collate prevalence data on: Proportion of children with CPP for neglect Proportion of children in schools at threshold level 3 because there are concerns about neglect. Monitor timeliness of decision making (preventing drift and delay). Children with child protection plans for 18 months and 2 years Children with repeat child protection plans To promote the application of the Graded Care profile tool. LSCB members to ensure appropriate professionals attend GCP2 training and use the tool in practice. Report on uptake and impact. To ensure professional attend training on neglect. LSCB members to ensure appropriate professionals attend LSCB neglect training Report on update and impact An important part of our response to childhood neglect is to ensure practitioners have the appropriate knowledge, skills and resources to both identify and assess neglect, leading to early intervention wherever possible. The LSCB provides a comprehensive training offer on this subject, with three separate courses covering the impact of neglect on child development, domestic abuse and the impact of it on the child, and the use of the Graded Care Profile 2 tool which agency
In this case, no hearing is held and the consent order is based on the payment plan that landlord and the tenant have agreed to. Voiding an LTB order An eviction order issued by the LTB for non-payment of rent usually allows the tenant to void the order by paying all the money they owe by the deadline in the order. If the tenant pays the landlord the money they owe before the deadline, the tenant can file a . A member will decide if the eviction order is void without holding a hearing. If the tenant pays all the money owed after the deadline, the tenant can file a . In this case, a member will hold a hearing to decide if the eviction order is void. Enforcement of an LTB order Most of the terms and conditions of LTB orders can be enforced through the courts. For example, if the tenant does not move out of the rental unit by the date in the eviction order, the order can be filed with the Court Enforcement Office (also known as the Sheriff’s office) to be enforced. An order for payment of money can be filed with the Small Claims Court for enforcement. Covers amendments, reviews and appeals. Once the LTB issues an order, it is final. The LTB will not change the order because a party does not like the decision or because a party believes that a different decision should have been made. For more information, read the brochure: . Amending an order If you notice a clerical mistake in the order, such as a spelling error in someone’s name or a calculation error, you have 30 days to file a to ask the member to correct the mistake. In your request, tell the member what the mistake is and why it should be corrected. There is no fee to make this request. For details, see . Asking the LTB to review an order You can ask the LTB to review an order on the grounds that a “serious error” has been made in the order. A serious error can be: LTB made an order it did not have the power to make The application was not processed fairly and this interfered with the rights of one of the parties
State Department Name: Contact Person Phone # Date Prepared Product Description Brand/Model: Unique Performance Factors Product Name: Product Name: Product Name: Product Name: Product Name: Product Name: Suppliers Product Meets Unique Performance Factors Why Are These Specific Factors Required? What Other Products Have Been Examined And Rejected And Why? Limit to Brand (LTB) Justification Worksheet
LTC and VA Resources for Patients, Family Members, Providers and other Stakeholders The table below lists possible root causes of high catheter utilization and potential interventions. Possible Root Causes Of High Catheter Utilization and Potential Interventions To Reduce The Long-Term Catheter Rate POSSIBLE ROOT CAUSES POTENTIAL INTERVENTIONS ESRD Management-Related Factors Lack of valid information about long-term benefits of permanent internal access (AVF or AVG) and that catheter placement at certain sites may limit future access options Increase educational awareness of benefits of permanent internal access (AVF or AVG) for patient’s optimal quality of life. Adopt belief that the preferred permanent vascular access is AVF. Lack of knowledge about K-DOQI Guidelines for vascular access Provide recent copy of K-DOQI Practice Guidelines and familiarize facility staff with contents Failure to establish a vascular access program and coordinator to implement and follow-up. Establish a vascular access program and select a coordinator or team for implementation and follow-up. Integrate into facility’s QI program. Failure of nephrologist, surgeon, or ESRD team to educate patients (preferably about risks/benefits of vascular access options and need to protect potential access sites Provide patient education, preferably or at the beginning of dialysis, about risks/benefits of vascular access options. Adopt belief that the preferred permanent vascular access is AVF. Late referral of patient by nephrologist (or primary physician) to vascular surgeon for permanent access placement, including waiting for completion of transplant evaluation before making access plans. Nephrologist did not refer patient to vascular surgeon in timely manner Use of vascular access assessment and referral algorithms. Refer patient to facility vascular access coordinator (or team) for assessment and follow-up. Lack of surgeon preference for AVFs Lack of surgical training/experience in placing AVFs. Catheter placed surgically because it is faster and technically easier to accomplish. Adopt belief that the preferred permanent vascular access is AVF. Encourage education/expertise in placing AVFs. Refer patient to surgeon with expertise in
summative feedback and guidance about transition between years Pre-planning activities such as ‘transitional’ briefings to support progression Planning activities and self-study opportunities to span vacations and academic years 5.2 Ensure that the retrieval of academic failure is and developmental Devising reassessment tasks that have purpose and offer creative opportunity Ensuring that processes to support re-taking assessment are clear and appropriate Ensure a planned programme of engagement for students that intermit or re-sit any part an academic year Goal 6: To foster and enhance a sense of community and belonging in the student experience Strategy Actions Team / Department Actions 6.1 Reinforce students individual and collective sense of purpose and ambition Embedding of co-curricular activities such as careers, employability and enterprise provision Review opportunities for personal and professional development planning Provide a coordinated range of opportunities for student leadership, volunteering, civic engagement, and work Provide greater opportunities for alumni and professional networking activities 6.2 Devise explicit opportunities for peer-to-peer support, mentoring and engagement Development and implement opportunities for peer mentoring and ‘buddying’ schemes Review and devise opportunities for peer-assessment and review Revise and align the Student Ambassador Scheme to support student engagement Goal 7: To ensure that all regulations and processes support student admission, retention, progression and achievement Strategy Actions Team / Department Actions 7.1 Systematically review all academic Common Credit Framework and associated policies Student Regulations Review and enhance liaison between Academic Registry / Quality and Standards, and Student Union
Please continue on a separate sheet if required (include your name). Education & Membership of Professional Bodies Please list any educational qualifications starting with the highest level first (ie if you have a degree, apprenticeship, A levels, GCSEs, etc). Please include current studies if applicable. University / College / School Course studied or Qualification Achieved (e.g. GCSE Mathematics) Grade
I hope that you find the information provided useful and sufficient on which to base your application. If you would like any further details or would like to discuss the post informally prior to application, please do not hesitate to contact Mrs L Podmore via e-mail at jobs@cheslynhay-high.staffs.sch.uk in the first instance or visit our webpage. Yours sincerely Director of Business and Finance
listening to children and young people (para 3.6) Parents, carers, Practitioners 1.5 All staff are aware of their own roles and responsibilities and those of the provider for safeguarding and protecting children (including support staff and volunteers). This includes awareness of e-safety and use of cameras and mobiles (para 3.4, 3.5, 3.6) Provider Parents, carers, Practitioners 1.6 The policy and procedures help staff to recognise the additional vulnerability of some children Provider
defined in Working Together to Safeguard Children 2015 e.g. CLA, children with disabilities and CPP (para 3.6, 3.13) Parents, carers, Practitioners 1.7 The provider has effective complaints policies and systems in place for professionals and users, which are compatible with the Early Years Statutory Framework (para 3.73) Provider Parents, carers, Practitioners 1.8 The provider has effective whistle blowing policies and Provider
Practitioners 6.3 If a referral is made to any other agency, and the response is unsatisfactory, the Designated Person is aware of how to escalate the issue using the provider’s policies and the LSCB protocol Provider Parents, carers, Practitioners 6.4 Any appropriate staff understand the threshold for making a referral to Children’s Services and can differentiate between a child welfare concern and a child protection concern Provider Parents, carers,
communicated with using their preferred communication method or language para IV, page 3 Parents, carers, Practitioners 7.3 Racial heritage, language, religion, faith, gender and disability is taken into account. Staff have received relevant training para IV, page 3 Provider Parents, carers, Practitioners Supporting evidence for Element 7: 7 Notes and records show evidence of this. Training logs and programme provide evidence of this
GUJARAT NATIONAL LAW UNIVERSITY APPLICATION FORM FOR LTC APPROVAL AND GRANT OF ADVANCE 1 Name of the Employee 2 Designation 3 Date of Entering into the Service 4 Pay Scale 5 Home Town as recorded in the Service Book 6 Whether spouse is employed and if so whether entitled to LTC 7 Whether the concession is to be availed for visiting home town and if so block for which LTC is to be availed. (As per the Directive) 8 Whether the concession is to visit anywhere in India, and if so block for which LTC is to be availed. (As per the Directive) 9 Mode of travel from the University to home town/place of visit by shortest route: Air/Rail/Bus (As per the entitlement) Encashment of 10 days Earned Leave along with LTC if required (if applicable) Yes/No 11 Persons in respect of whom LTC is proposed to be availed. S. No Name Age Relationship with the Employee Occupation Income 1. 2. 3. 4. 5. 6. 12 Amount of advance required (in ₹) Details of journey (s) to be performed by the Employee and the members of his/her family. Departure Arrival Remarks
The Losing Trick Count How Many Losers have I? The essence of the Losing Trick Count approach is assessing… How Many Losers have I? A Single Suit... The Rule of 3: Under the Losing Trick Count, only the first three cards in any suit count as possible losers (the logic being that in a Trump Suit contract you will be unlikely to have ‘mirror image’ hands with more than three cards in both hands in a side suit – so you will be able to ruff any ‘long losers’…) Aces; Kings; and : The second source of losers under the Losing Trick Count approach are any cards that are not an Ace; King; or Queen. Example 1: Take this suit: K Q x (x) The ‘Rule of 3’ says that the 4th card in the suit (in brackets) does not count as a loser, so we are left with K; Q; x… The King and Queen are not losers, so under the Losing Trick Count, this suit = 1 Loser Example 2: Now take this suit: x x x (x) The ‘Rule of 3’ says that the 4th card in the suit (in brackets) does not count as a loser… But without an Ace; King or Queen, the first three cards are all losers, so under the Losing Trick Count, this suit = 3 Losers
TABLE OF CONTENTS SUMMARY 3 CONCLUSIONS AND REGULATORY OBLIGATIONS 3 ASSESSMENT DETAILS 5 1. APPLICANT AND NOTIFICATION DETAILS 5 2. IDENTITY OF CHEMICAL 5 3. COMPOSITION 5 4. PHYSICAL AND CHEMICAL PROPERTIES 5 5. INTRODUCTION AND USE INFORMATION 6 6. HUMAN HEALTH IMPLICATIONS 7 6.1. Exposure Assessment 7 6.1.1. Occupational Exposure 7 6.1.2. Public Exposure 7 6.2. Human Health Effects Assessment 9 6.3. Human Health Risk Characterisation 10 6.3.1. Occupational Health and Safety 10 6.3.2. Public Health 10 7. ENVIRONMENTAL IMPLICATIONS 10 7.1. Environmental Exposure & Fate Assessment 10 7.1.1. Environmental Exposure 10 7.1.2. Environmental Fate 11 7.1.3. Predicted Environmental Concentration (PEC) 11 7.2. Environmental Effects Assessment 11 7.2.1. Predicted No-Effect Concentration 12 7.3. Environmental Risk Assessment 12 Appendix A: Physical and Chemical Properties 13 Appendix B: Toxicological Investigations 15 B.1. Acute toxicity – oral 15 B.2. Acute toxicity – dermal 15 B.3. Acute toxicity – inhalation 16 B.4. Irritation – skin 17 B.5. Irritation – eye 17 B.6. Skin sensitisation – mouse local lymph node assay (LLNA) 18 B.7. Repeat dose toxicity 19 B.8. Genotoxicity – bacteria 20 B.9. Genotoxicity – in vitro 21 Appendix C: Environmental Fate and Ecotoxicological Investigations 23 C.1. Environmental Fate 23 C.1.1. Ready biodegradability 23 C.2. Ecotoxicological Investigations 23 C.2.1. Acute toxicity to fish 23 C.2.2. Acute toxicity to aquatic invertebrates 24 C.2.3. Algal growth inhibition test 24 C.2.4. Inhibition of microbial activity 25 BIBLIOGRAPHY 26
Partition Coefficient log Pow = 3.78 EC Council Regulation No 440/2008 A.8 Partition Coefficient Remarks HPLC Method. The column temperature was 30°C. The partition coefficient of the notified chemical was determined to be POW = 6.02 × 103 or logPOW = 3.78. Firmenich (2006) Surface Tension 69.7 mN/m at 20.2 ± 0.5 °C EC Council Regulation No 440/2008 A.5 Surface Tension. Remarks Concentration:7.61 x 10-2 g/L Safepharm (2007b) Adsorption/Desorption – screening test log KOC = 2.78 Method of C19 of Commission Directive 2001/59/EC (which constitutes Annex V of Council Directive 67/548/EEC) Remarks HPLC method. The log KOC was determined to be 2.78 for the notified chemical. Safepharm (2007b) Flash Point 67 ± 2 °C at 101.3 kPa EC Council Regulation No 440/2008 A.9 Flash Point. Remarks Closed cup method Firmenich (2006) Autoignition Temperature 228 ± 5 °C EC Council Regulation No 440/2008 A.15 Auto-Ignition Temperature (Liquids and Gases). SafePharm (2007a) Explosive Properties Predicted Negative EC Council Regulation No 440/2008 A.14 Explosive Properties. Remarks Predicted negative based on chemical structure and oxygen balance. Safepharm (2007a) Oxidizing Properties Predicted Negative EC Council Regulation No 440/2008 A.21 Oxidizing Properties (Liquids). Remarks Predicted negative based on chemical structure. Safepharm (2007a)
Metabolic Activation Test Substance Concentration (μg/mL) Exposure Period Harvest Time Absent Test 1 0*, 19.53, 39.06*. 78.13*, 156.25, 312.5*, 625, 937.5*, 1250 4 24 Test 2 0*, 15, 30, 60*, 120*, 240*, 360* 24 24 Present Test 1 0*, 19.53, 39.06*. 78.13*, 156.25, 312.5*, 625, 937.5*, 1250 4 24 Test 2 0*, 30, 60*, 120, 240*, 480*, 960* 4 24 *Cultures selected for metaphase analysis. Metabolic Activation Test Substance Concentration (µg/mL) Resulting in: Cytotoxicity in Preliminary Test Cytotoxicity in Main Test Precipitation Genotoxic Effect Absent Test 1 ≥ 1,250 > 937.5 ≥ 156.25 negative Test 2 ≥ 312.5 > 360 ≥ 120 negative Present Test 1 ≥ 1,250 > 937.5 ≥ 156.25 negative Test 2 ≥ 1,250 > 960 ≥ 120 negative Remarks - Results In both tests 1 and 2, the test substance did not induce a significant increase in the numbers of polyploid cells or in the frequency of cells with chromosome aberrations at any dose level in either of the exposure groups. The vehicle control and positive control cultures gave values of chromosome aberrations within the expected range, indicating that the metabolic activation system and test method were satisfactory. The notified chemical was not clastogenic to human lymphocytes treated in vitro under the conditions of the test. Harlan (2012)
the amount of chemical being introduced has increased from 100 tonnes, or is likely to increase, significantly; if the chemical has begun to be manufactured in Australia; additional information has become available to the person as to an adverse effect of the chemical on occupational health and safety, public health, or the environment. The Director will then decide whether a reassessment (i.e. a secondary notification and assessment) is required. Material Safety Data Sheet The MSDS of the notified chemical provided by the notifier was reviewed by NICNAS. The accuracy of the information on the MSDS remains the responsibility of the applicant.
FULL PUBLIC REPORT APPLICANT AND NOTIFICATION DETAILS APPLICANT(S) Orica Australia Pty Ltd (ABN: 99 004 117 828) 1 Nicholson Street, Melbourne VIC 3000 NOTIFICATION CATEGORY Limited: Synthetic polymer with Mn 1000 Da. EXEMPT INFORMATION (SECTION 75 OF THE ACT) Data items and details claimed exempt from publication: Chemical names, Other names, CAS Number, Molecular formula, Structural Formula, Molecular weight, Spectral data, Identity and concentration of impurities, Import volume, Concentration of the polymer in products VARIATION OF DATA REQUIREMENTS (SECTION 24 OF THE ACT) Variation to the schedule of data requirements is claimed as follows: Density, Vapour pressure, Partition Coefficient, Adsorption/desorption, Dissociation Constant, Flammability Limit, Flashpoint, Autoignition Temperature, Explosive properties PREVIOUS NOTIFICATION IN AUSTRALIA BY APPLICANT(S) None NOTIFICATION IN OTHER COUNTRIES None IDENTITY OF CHEMICAL MARKETING NAME(S) Solsperse 76500 ANALYTICAL DATA Reference NMR, IR, HPLC, GC, GPC and MS spectra were provided to confirm the structure. COMPOSITION DEGREE OF PURITY > 95% LOSS OF MONOMERS, OTHER REACTANTS, ADDITIVES, IMPURITIES None under normal conditions of use. The notified polymer contains groups susceptible to hydrolysis. Under extreme heat conditions, such as in a fire the notified polymer will burn emitting toxic fumes, gases or vapours including oxides of carbon and nitrogen. DEGRADATION PRODUCTS Stable under normal conditions of use and therefore the loss of any monomers, other reactants, additives and impurities is not expected. PHYSICAL AND CHEMICAL PROPERTIES APPEARANCE AT 20ºC AND 101.3 kPa: Soft yellowish solid
Australia at 50% dispersion in solvent in sealed steel 20 kg or 180 kg drums. MAXIMUM INTRODUCTION VOLUME OF NOTIFIED CHEMICAL (100%) OVER NEXT 5 YEARS Year 1 2 3 4 5 Tonnes 3-10 3-10 3-10 3-10 3-10
Appendix B: Toxicological Investigations Toxicological investigations were conducted on notified chemical with a purity of >90%. Acute toxicity – oral Notified chemical OECD TG 423 Acute Oral Toxicity – Acute Toxic Class Method. EC Directive 92/69/EEC B.1tris Acute Oral Toxicity – Acute Toxic Class Method. Species/Strain Rat/Sprague-Dawley CD Vehicle Distilled water Remarks - Method No significant protocol deviations. Group Number and Sex of Animals Dose mg/kg bw Mortality 1 3 (F) 2000 0 2 3 (M) 2000 0 LD50 >2000 mg/kg bw Signs of Toxicity Clinical signs of toxicity noted were dark red-coloured diarrhoea and staining of the urine and faeces. Animals recovered two or four days after dosing. There were no deaths. Effects in Organs No abnormalities were noted at necropsy. Remarks - Results All animals showed an expected gain in bodyweight during the study. The notified chemical is of low toxicity via the oral route. SafePharm Laboratories Ltd (2000f) Acute toxicity – dermal Notified chemical OECD TG 402 Acute Dermal Toxicity – Limit Test. EC Directive 92/69/EEC B.3 Acute Toxicity (Dermal) – Limit Test. Species/Strain Rat/Sprague-Dawley CD Vehicle Test material was moistened with distilled water. Type of dressing Semi-occlusive. Remarks - Method No significant protocol deviations. The animals were observed for fourteen days after the day of treatment and were then killed for gross pathological examination. Group Number and Sex of Animals Dose mg/kg bw Mortality 1 5 2000 0 2 5 2000 0 LD50 >2000 mg/kg bw Signs of Toxicity - Local No signs of dermal irritation were noted during the study. Pink-coloured staining was noted at the treatment sites of all animals one to three days after dosing. The staining prevented the accurate evaluation of erythema at the treatment sites of all animals one day after dosing. coloured
FULL PUBLIC REPORT APPLICANT AND NOTIFICATION DETAILS APPLICANT(S) DIC Australia Pty Ltd (ABN 12 000 079 550) 42 Sunmore Close, Heatherton VIC 3202 NOTIFICATION CATEGORY Limited-small volume: Chemical other than polymer (1 tonne or less per year). EXEMPT INFORMATION (SECTION 75 OF THE ACT) Data items and details claimed exempt from publication: Chemical name, Other names, CAS number, Molecular formula, Structural formula, Molecular weight, Spectral data, Method of detection and determination, Purity, Additives, Import volume, Identity of recipients VARIATION OF DATA REQUIREMENTS (SECTION 24 OF THE ACT) No variation to the schedule of data requirements is claimed. PREVIOUS NOTIFICATION IN AUSTRALIA BY APPLICANT(S) None NOTIFICATION IN OTHER COUNTRIES None IDENTITY OF CHEMICAL MARKETING NAME(S) Y-513 Symuler Fast Yellow 4407NF (containing 3-8% notified chemical) MOLECULAR WEIGHT >500 Da ANALYTICAL DATA Reference NMR, IR, HPLC, MS(ESI), ICP-AES, UV spectra were provided. COMPOSITION The notified chemical is a reaction mixture consisting of several structurally related azo components derived from 3,3’-dichlorobenzidine. DEGREE OF PURITY >95% HAZARDOUS IMPURITIES/RESIDUAL MONOMERS None. The notifier has indicated that they expect that the notified chemical does not contain impurities of 3,3’- dichlorobenzidine at levels greater than 10ppm. PHYSICAL AND CHEMICAL PROPERTIES APPEARANCE AT 20ºC AND 101.3 kPa: Yellow powder
Boiling Point Not determined Decomposed prior to melting Density 1630 kg/m3 at 19.5 ± 0.5oC Measured Vapour Pressure < 2 x 10-8 kPa at 25oC Measured Water Solubility 350-360 g/L at 20oC Measured Hydrolysis as a Function of pH Stable (half-life > 1 year at pH 4, 7 and 9) Measured Partition Coefficient (n-octanol/water) log Pow = -4.88 at 21oC Measured Surface Tension 71.9 mN/m (1 g/L solution) at 21.8 ± 0.2oC Measured Adsorption/Desorption log Koc < 1.25 at 40C Measured Dissociation Constant pKa = 6.35, 2.22, 1.62, ≤ -0.71 Calculated Particle Size Inhalable fraction (<100 m): 32.3% Respirable fraction (<10 m): 1.14% Measured Flash Point Not determined Low vapour pressure solid Solid Flammability Not highly flammable Measured Autoignition Temperature Does not self-ignite below 400oC Measured Explosive Properties Not explosive Measured Oxidising Properties Not expected to be oxidising Estimated DISCUSSION OF PROPERTIES For full details of tests on physical and chemical properties, please refer to Appendix A. Reactivity The notified chemical is not expected to be reactive under normal conditions of use. INTRODUCTION AND USE INFORMATION MODE OF INTRODUCTION OF NOTIFIED CHEMICAL (100%) OVER NEXT 5 YEARS The notified chemical will be imported as a component (<5%) of inkjet printer ink contained within sealed ink cartridges. MAXIMUM INTRODUCTION VOLUME OF NOTIFIED CHEMICAL (100%) OVER NEXT 5 YEARS Year 1 2 3 4 5 Tonnes <1 <1 <1 <1 <1 PORT OF ENTRY Sydney IDENTITY OF MANUFACTURER/RECIPIENTS Canon Australia Pty Ltd and office equipment retailers and offices nationwide. TRANSPORTATION AND PACKAGING Imported ink cartridges (5 mL – 900 mL) containing the notified chemical (each individually sealed in a plastic bag and packaged in a box) will be stored at the notifier’s warehouse prior to distribution to offices and office equipment retailers nationwide. USE The notified chemical will be used as a component (<5%) in ink cartridges for use in inkjet printers. OPERATION DESCRIPTION No manufacture or reformulation will occur in Australia. Sealed ink cartridges containing the notified chemical will be distributed to commercial and retail centres and handled by service technicians, office workers or the public, who will replace spent cartridges in printers as necessary.
No degradation products are expected to form under the proposed use of the notified polymer. PHYSICAL AND CHEMICAL PROPERTIES Appearance at 20ºC and 101.3 kPa: Extremely pale yellow powder Property Value Data Source/Justification Melting Point/Range 68.85 to 72.85oC Measured Boiling point Not determined -- Density 1.06 x 103 kg/m3 at 21oC Measured Vapour Pressure <1.2 x 10-6 kPa at 25oC Measured Water Solubility < 1.1 mg/L at 20oC Visually estimated Hydrolysis as a Function of pH Not determined No hydrolysable functionalities are present in the notified polymer. Partition Coefficient (n-octanol/water) log POW ≥ 12.2 Estimated by an atom fragment/constant methodology for a representative low molecular weight oligomer. Adsorption/Desorption log Koc > 5.63 Measured. Dissociation Constant Not determined No dissociable functionalities are present in the notified polymer. Particle Size Inhalable fraction (<100 m): 12.8% Respirable fraction (<10 m): 0.335% Measured Flammability (solids) Not highly flammable Measured Autoignition Temperature Not expected to self-ignite below its melting temperature Measured Explosive Properties Not expected to be explosive Estimated (based on structural indication of explosive properties) Oxidizing Properties Not expected to have oxidising properties Estimated (based on structural indication of oxidising properties) Discussion of Properties For full details of tests on physical and chemical properties, refer to Appendix A. Reactivity The polymer is expected to be stable under normal conditions of use. INTRODUCTION AND USE INFORMATION (100%) 5 The notified chemical will not be manufactured in and will be imported into as a component of fully finished toner cartridge. (100%) 5 Year 1 2 3 4 5 Tonnes <1 <1 <1 <1 <1 Fuji Xerox Australia Pty Ltd
Therefore, the notified chemical is not considered to pose a risk to the aquatic environment under the proposed use and introduction volume. 8. CONCLUSIONS AND REGULATORY OBLIGATIONS Hazard classification Based on the provided data the notified chemical is classified as hazardous according to the Approved Criteria for Classifying Hazardous Substances [NOHSC:1008(2004)]. The following risk phrase applies to the notified chemical: C: R34 Causes burns and As a comparison only, the classification of the notified chemical using the Globally Harmonised System for the Classification and Labelling of Chemicals (GHS) (United Nations 2009) is presented below. This system is not mandated in and carries no legal status but is presented for information purposes. Hazard category Hazard statement Skin Corrosion/Irritation Category 1 Causes severe skin burns and eye damage Human health risk assessment Under the conditions of the occupational settings described, the notified chemical is not considered to pose an unacceptable risk to the health of workers. When used in the proposed manner, the notified chemical is not considered to pose an unacceptable risk to public health. Environmental risk assessment On the basis of the reported use pattern, the notified chemical is not expected to pose a risk to the environment. Recommendations Hazard Classification and Labelling The Office of the ASCC, Department of Employment and Workplace Relations (DEWR), should consider the following health hazard classification for the notified chemical: C: R34 Causes burns Use the following cut-off concentrations and risk phrases for products/mixtures containing the notified chemical: Conc ≥ 10%: R34 ≥ 5% Conc < 10%: R36; R38 Occupational Health and Safety
Appendix A: Physical and Chemical Properties Water Solubility 0.060 g/L at 20oC EC Directive 92/69/EEC A.6 Water Solubility. Remarks Flask Method, with HPLC/UV analysis. The chromatographic analysis apparently shows that the test item isn’t stable in water. Additional peaks in the chromatogram of the notified chemical were attributed to hydrolysis products, although they were not identified. Kesla Forschung and Service GmbH, (2006) Particle Size Inhalable fraction (<100 m): 100% Respirable fraction (<10 m): > 85% MMAD = 1.8 -3.1 m OECD TG 110 Particle Size Distribution/Fibre Length and Diameter Distributions. Range (m) Mass (%) 29.5 1.8 – 2.4 18.2 1.7 – 3.4 8.5 3.2 – 9.3 5.5 3.7 – 9.3 2.8 23.9 – 35.9 1.2 25.7 – 33.4 < 1.2 16.1 – 32.3 Remarks The particle size was measured as part of the acute inhalation toxicity test. A sample for particle size testing was taken from each of the 4 dose groups. BASF (1990) Flammability Not highly flammable EC Directive 92/69/EEC A.10 Flammability (Solids). Remarks The test substance could not be ignited although it did melt and emit sparks while in contact with the ignition source. NOTOX (2003a)
FULL PUBLIC REPORT Full report amended on 23/06/2010. APPLICANT AND NOTIFICATION DETAILS APPLICANT(S) Roland DG Australia Pty Ltd (ABN: 13007023690) NOTIFICATION CATEGORY Limited-small volume: Chemical other than polymer (1 tonne or less per year). EXEMPT INFORMATION (SECTION 75 OF THE ACT) Data items and details claimed exempt from publication: Chemical names, Other names, CAS Number, Molecular formula, Structural Formula, Molecular weight, Spectral data. Purity, Non-hazardous impurities, Details of use, Concentration in product and Import volumes. VARIATION OF DATA REQUIREMENTS (SECTION 24 OF THE ACT) Variation to the schedule of data requirements is claimed as follows: Melting point, Boiling point, Vapour pressure, Water solubility, Hydrolysis as a function of pH, Partition coefficient, Absorption/Desorption, Dissociation constant, Flash point, Flammability limits, Autoignition Temperature, Reactivity and Bioaccumulation. PREVIOUS NOTIFICATION IN AUSTRALIA BY APPLICANT(S) None. NOTIFICATION IN OTHER COUNTRIES None. IDENTITY OF CHEMICAL MARKETING NAME(S) Polyalkyleneglycol ethylmethylether COMPOSITION DEGREE OF PURITY >98 % HAZARDOUS IMPURITIES/RESIDUAL MONOMERS Unknown NON HAZARDOUS IMPURITIES/RESIDUAL MONOMERS (>1% by weight) Unknown
the importation volume exceeds one tonne per annum notified chemical; the notified chemical is imported in any form other than a component of printing ink at up to 30% concentration in sealed cartridges; the ink containing the notified chemical is used for printing in other than commercial facilities or Under Section 64(2) of the Act; if the function or use of the chemical has changed from a component of printing ink or is likely to change significantly; the amount of chemical being introduced has increased or is likely to increase, significantly; the chemical has begun to be manufactured in Australia; additional information has become available to the person as to an adverse effect of the chemical on occupational health and safety, public health, or the environment. The Director will then decide whether a reassessment (i.e. a secondary notification and assessment) is required. Material Safety Data Sheet The MSDS of product containing the notified chemical provided by the notifier was reviewed by NICNAS. The accuracy of the information on the MSDS remains the responsibility of the applicant.
Full Public Report NIR-IM1 APPLICANT AND NOTIFICATION DETAILS Fuji Xerox Australia Pty Ltd NSW 2113 Limited-small volume: Chemical other than polymer (1 tonne or less per year). 75 Data items and details claimed exempt from publication: Chemical name, Other names, CAS number, Molecular formula, Structural formula, Molecular weight, Methods of detection and determination, Spectral data, Import volume, Use details, Identity of manufacturer/recipients 24 No variation to the schedule of data requirements is claimed. NCE, 2007 , 2007 IDENTITY OF CHEMICAL NIR-IM1, Cyan Toner (product containing the notified chemical at <1%) >1000 Da Reference NMR, IR, HPLC, UV/Vis spectra were provided. COMPOSITION ALL >99% (>1% PHYSICAL AND CHEMICAL PROPERTIES
Appendix A: Physical and Chemical Properties Melting Point/Freezing Point >40oC Remarks MSDS Croda Chemicals Ltd, Boiling Point 1037oC at 101.3 kPa Remarks The notified chemical is likely to decompose well below this value. QSAR data (EPIv4.0) Density ~1020 kg/m3 at 45oC Remarks Analogue data for Ceteth MSDS Croda Chemicals Ltd, Vapour Pressure 1.34 x 10-32 kPa at 25oC Remarks QSAR data (EPIv4.0)
APPENDIX C: ENVIRONMENTAL FATE AND ECOTOXICOLOGICAL INVESTIGATIONS Environmental Fate Ready biodegradability TEST SUBSTANCE Analogue of notified chemical METHOD International Standards Organisation method 7827 “Water Quality- Evaluation in an Aqueous Medium of the Aerobic Biodegradability of Organic Compounds, Method by Dissolved Organic Carbon” (1984) Inoculum Aerobically growing activated sludge from pilot scale sewage treatment plant Exposure Period Not stated Auxiliary Solvent None Analytical Monitoring Dissolved organic carbon determination Remarks - Method The culture medium was an aqueous solution containing several minerals and micronutrients and set to a pH of ~7. The test substance was added to the culture medium to give a DOC of 30 ppm. The medium was inoculated with 7 mL fresh aerobic activated sludge to give a suspended solids content of 30 mg/L. The culture was shaken continuously at 140- 150 rpm for the duration of the test. The temperature was maintained at 27 ± 2ºC which is outside the range specified in the method (20 to 25ºC). The biodegradation test included duplicate cultures of the test substance, a blank culture (containing only test medium and activated sludge inoculum), an inhibition test culture and an abiotic test culture. The inhibition test culture contained the test substance and sodium acetate both at levels of 30 ppm DOC. The abiotic blank culture contained the test substance in an inoculated culture that was sterilised by addition of 4 mL/L hypochlorite solution. Samples for DOC analysis (~35 mL) were withdrawn at the required intervals and centrifuged at 2,275 g for 15 min. RESULTS Test substance Sodium Acetate Day % Degradation* Day % Degradation 2 ~95% 3 >94% 7 ~98% *Information taken from a graph (DOC vs time) Remarks - Results The duration of the test was not stated, however graphical information in the paper indicates the test substance was analysed over 9 days which is adequate considering it has a measured biodegradability half life of <9.84 h. CONCLUSION The test substance and hence the notified chemical is readily biodegradable TEST FACILITY Exempt information
Full Public Report Polymer in BYK-LP N 21444 WS APPLICANT AND NOTIFICATION DETAILS Nuplex Industries (Aust.) Pty Ltd (ABN 25 000 045 572) BOTANY NSW 2019 Limited: Synthetic polymer with Mn 1000 Da. 75 Data items and details claimed exempt from publication: chemical name, other names, molecular and structural formulae, molecular weight, polymer constituents, residual monomers/impurities, use details, import volume 24 Variation to the schedule of data requirements is claimed as follows: Melting/Freezing Point, Boiling Point, Density, Vapour Pressure, Water Solubility, Hydrolysis as a Function of pH, Partition Coefficient, Adsorption/Desorption, Dissociation Constant, Particle Size, Flash Point, Flammability Limits, Autoignition Temperature, Explosive Properties None (2005) IDENTITY OF CHEMICAL BYK-LP N 21444 WS (containing <30% notified polymer) CAS Not assigned BYK-LP N 20733 (notified polymer) Mn >1000 Da. Reference IR, and GPC spectra were provided. COMPOSITION >99% (> 1% None None
Sax (1986) Hydrolysis as a Function of pH t½ ~89 years at 25°C and pH 7 The half-life at 25°C was extrapolated from kinetic measurements made under aqueous alkaline conditions at temperatures of 64°C and 84°C. Sabaliūnas et al. (1996) Partition Coefficient log Kow = 0.98 Literature data (Hansch et al., 1995) Remarks The log octanol-water partition coefficient (log Kow) was calculated to be 1.38 (KOWWIN (v1.67), US EPA (2009). Hansch et al. (1995) Adsorption/Desorption – screening test log Koc = 1.43 Literature data (Sabljić, 1987) Remarks The soil adsorption coefficient was calculated to be 41.55 (log Koc = 1.62) by the MCI method and 24.65 (log Koc = 1.39) by the Kow method (KOCWIN (v2.00), US EPA (2009)). The notified chemical is expected to be highly mobile in soil. Sabljić (1987) Dissociation Constant pKa = 9.7 at 25°C The pKa value of the notified polymer (pKa = 9.7 at 25°C) was inferred from the pKa value of the hydrochloride salt of alpha-propyl-2-methyl-propioanilide, as the amidic bond of the propioanilide is similar to the amidic bond of the notified chemical. Sabaliūnas et al. (1996)
TABLE OF CONTENTS Full Public Report 4 1. APPLICANT AND NOTIFICATION DETAILS 4 2. IDENTITY OF CHEMICAL 4 3. 4 4. PHYSICAL AND CHEMICAL PROPERTIES 4 5. INTRODUCTION AND USE INFORMATION 5 6. HUMAN HEALTH IMPLICATIONS 6 6.1 Exposure 6 6.1.1 Occupational exposure 6 6.1.2. Public exposure 6 6.2. Human health effects assessment 6 6.3. Human health risk characterisation 7 6.3.1. Occupational health and safety 7 6.3.2. Public health 7 7. ENVIRONMENTAL IMPLICATIONS 8 7.1. Environmental Exposure & Fate Assessment 8 7.1.1 Environmental Exposure 8 7.1.2 Environmental fate 8 7.1.3 Predicted Environmental Concentration (PEC) 9 7.2. Environmental effects assessment 9 7.2.1 Predicted No-Effect Concentration 9 7.3. Environmental risk assessment 10 8. CONCLUSIONS AND REGULATORY OBLIGATIONS 10 Appendix A: Physical and Chemical Properties 12 Appendix B: Toxicological Investigations 15 B.1. Acute toxicity – oral 15 B.2. Acute toxicity – dermal 15 B.3. Irritation – skin 16 B.4. Irritation – eye 16 B.5. Skin sensitisation – mouse local lymph node assay (LLNA) 17 B.6. Repeat dose toxicity 18 B.7. Genotoxicity – bacteria 19 B.8. Genotoxicity – in vitro 20 Appendix C: Environmental Fate and Ecotoxicological Investigations 22 C.1. Environmental Fate 22 C.1.1. Ready biodegradability 22 C.2. Ecotoxicological Investigations 22 C.2.1. Acute toxicity to fish 22 C.2.2. Acute toxicity to aquatic invertebrates 23 C.2.3. Algal growth inhibition test 24 C.2.4. Inhibition of microbial activity 25 Bibliography 26
Full Public Report INK BH11 C APPLICANT AND NOTIFICATION DETAILS Brother International (Aust) Pty Ltd (17 001 393 835) , Level 3, Building A PARK NSW 2113 Limited-small volume: Chemical other than polymer (1 tonne or less per year). 75 Data items and details claimed exempt from publication: chemical name, other names, CAS number, molecular and structural formulae, molecular weight, use details, import volume and identity of recipients. 24 No variation to the schedule of data requirements is claimed. None (2009) IDENTITY OF CHEMICAL INK BH11 C > 500 Da Reference NMR, IR, HPLC, UV spectra and Karl Fischer titration data were provided. COMPOSITION > 95% PHYSICAL AND CHEMICAL PROPERTIES Appearance at 20ºC and 101.3 kPa: Blue powder Property Value Data Source/Justification Melting Point Decomposed from ~330oC Measured Boiling Point Not determined Decomposes on melting. Density 1750 kg/m3 at 21oC Measured Vapour Pressure < 1.3 x 10-7 kPa at 25oC Measured Water Solubility 201 g/L to 220 g/L at 20 ± 0.5oC Measured Hydrolysis as a Function of pH t½ >1 year at 25°C, pH 4–9 Measured Partition Coefficient (n-octanol/water) log Pow < -2.83 at 22.7 ± 1.0oC Measured Surface Tension 72.0 mN/m at 21.6 ± 0.5oC Measured Adsorption/Desorption log Koc < 1.25 at 40C Measured Dissociation Constant Not determined The notified chemical is a salt and is expected to be ionised under
(B) (2) Consultant offices ☐ check if not included in project min. floor area 100 sf (3) Dietary consultant office located convenient to kitchen area 150.540 REHABILITATION SERVICE AREAS ☐ check if not included in project (B) Physical therapy room (1) min. floor area 200 sf min. dimension 10'-0" Nurse call System: Call station 150.850(A) (2) closet for storage of supplies & equipment handwashing sink with hot & cold running water (A)(4) Required Equipment: (a) Treatment table, footstool & chairs (b) Adequate linen supply (c) Sanitary waste containers (d) Hamper for soiled linen (e) Curtains or cubicles to assure privacy (f) Desk or table & chair for clerical use (A)(3) Rehabilitation service program also providing services to outpatients ☐ check if not included in project (a) direct entrance from outside accessible to persons with disabilities or direct access from main lobby accessible to persons with disabilities (b) parking convenient to entrance to rehabilitation program area; (c) patient toilet rooms conveniently located near rehabilitation service program areas separate from those serving nursing units Ventilation: Min. 10 air changes/hour Exhaust Nurse call System: Emergency pull-cord call station &(C) 150.850(B) staff toilet rooms conveniently located near rehabilitation service program areas separate from those serving nursing units Ventilation: Min. 10 air changes/hour Exhaust &(C) (d) adequate waiting & reception areas; (e) record storage (f) office space (B)(3) dressing facilities & lockers provided for outpatient use
Metabolic Activation Test Substance Concentration (µg/plate) Resulting in: Cytotoxicity Precipitation Genotoxic Effect Absent Test 1 >5000 ≥333 >5000 Test 2 >5000 ≥1000 >5000 Present Test 1 >5000 ≥667 >5000 Test 2 >5000 ≥1000 >5000 The notified polymer not mutagenic to bacteria under the conditions of the test. DuPont (2010f)